Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Gains from Investment Securities: 2012-2025

Historic Gains from Investment Securities for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $2.8 million.

  • Veracyte's Gains from Investment Securities rose 29.08% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year increase of 112.26%. This contributed to the annual value of $10.6 million for FY2024, which is 57.08% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Gains from Investment Securities is $2.8 million, which was up 18.24% from $2.4 million recorded in Q2 2025.
  • Veracyte's 5-year Gains from Investment Securities high stood at $9.5 million for Q1 2025, and its period low was $418,000 during Q2 2022.
  • Moreover, its 3-year median value for Gains from Investment Securities was $2.4 million (2025), whereas its average is $2.9 million.
  • Per our database at Business Quant, Veracyte's Gains from Investment Securities crashed by 78.64% in 2022 and then soared by 216.02% in 2023.
  • Quarterly analysis of 5 years shows Veracyte's Gains from Investment Securities stood at $722,000 in 2021, then decreased by 26.87% to $528,000 in 2022, then spiked by 113.45% to $1.1 million in 2023, then soared by 190.51% to $3.3 million in 2024, then rose by 29.08% to $2.8 million in 2025.
  • Its Gains from Investment Securities was $2.8 million in Q3 2025, compared to $2.4 million in Q2 2025 and $9.5 million in Q1 2025.